Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The SWI/SNF chromatin remodeling subunit BAF57 is a critical regulator of estrogen receptor function in breast cancer cells.

García-Pedrero JM, Kiskinis E, Parker MG, Belandia B.

J Biol Chem. 2006 Aug 11;281(32):22656-64.

PMID:
16769725
2.

Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.

Zhang H, Xie X, Zhu X, Zhu J, Hao C, Lu Q, Ding L, Liu Y, Zhou L, Liu Y, Huang C, Wen C, Ye Q.

J Biol Chem. 2005 Dec 30;280(52):43188-97.

PMID:
16219765
3.

Identification of BAF57 mutations in human breast cancer cell lines.

Kiskinis E, García-Pedrero JM, Villaronga MA, Parker MG, Belandia B.

Breast Cancer Res Treat. 2006 Jul;98(2):191-8.

PMID:
16538531
4.

Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient.

Villaronga MA, López-Mateo I, Markert L, Espinosa E, Fresno Vara JA, Belandia B.

Breast Cancer Res Treat. 2011 Aug;128(3):891-8. doi: 10.1007/s10549-011-1492-4.

PMID:
21465167
5.

BRD7, a subunit of SWI/SNF complexes, binds directly to BRCA1 and regulates BRCA1-dependent transcription.

Harte MT, O'Brien GJ, Ryan NM, Gorski JJ, Savage KI, Crawford NT, Mullan PB, Harkin DP.

Cancer Res. 2010 Mar 15;70(6):2538-47. doi: 10.1158/0008-5472.CAN-09-2089.

6.
7.

Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.

Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K.

Cancer Res. 2007 Apr 15;67(8):3955-62.

8.

Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies.

Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE.

J Cell Physiol. 2001 Jan;186(1):136-45.

PMID:
11147808
9.

The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene.

Annicotte JS, Chavey C, Servant N, Teyssier J, Bardin A, Licznar A, Badia E, Pujol P, Vignon F, Maudelonde T, Lazennec G, Cavailles V, Fajas L.

Oncogene. 2005 Dec 8;24(55):8167-75.

11.

Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.

Link KA, Balasubramaniam S, Sharma A, Comstock CE, Godoy-Tundidor S, Powers N, Cao KH, Haelens A, Claessens F, Revelo MP, Knudsen KE.

Cancer Res. 2008 Jun 15;68(12):4551-8. doi: 10.1158/0008-5472.CAN-07-6392.

12.

Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.

Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, Hallett M, Giguère V.

Cancer Res. 2009 Aug 1;69(15):6149-57. doi: 10.1158/0008-5472.CAN-09-1251.

13.

Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein.

Singh RR, Barnes CJ, Talukder AH, Fuqua SA, Kumar R.

Cancer Res. 2005 Nov 15;65(22):10594-601.

14.

Estrogenically regulated LRP16 interacts with estrogen receptor alpha and enhances the receptor's transcriptional activity.

Han WD, Zhao YL, Meng YG, Zang L, Wu ZQ, Li Q, Si YL, Huang K, Ba JM, Morinaga H, Nomura M, Mu YM.

Endocr Relat Cancer. 2007 Sep;14(3):741-53.

15.

Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.

Travaglini L, Vian L, Billi M, Grignani F, Nervi C.

Int J Biochem Cell Biol. 2009 Jan;41(1):225-34. doi: 10.1016/j.biocel.2008.08.019.

PMID:
18789398
16.

Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.

Qiu J, Wang X, Guo X, Zhao C, Wu X, Zhang Y.

Oncol Rep. 2009 Oct;22(4):935-41.

PMID:
19724876
17.

Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.

Maor S, Mayer D, Yarden RI, Lee AV, Sarfstein R, Werner H, Papa MZ.

J Endocrinol. 2006 Dec;191(3):605-12.

18.

Ciz1, a Novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action.

den Hollander P, Rayala SK, Coverley D, Kumar R.

Cancer Res. 2006 Nov 15;66(22):11021-9.

19.

NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells.

Gionet N, Jansson D, Mader S, Pratt MA.

J Cell Biochem. 2009 Jun 1;107(3):448-59. doi: 10.1002/jcb.22141.

PMID:
19350539
Items per page

Supplemental Content

Support Center